CMVYX | JVMCX | CMVYX / JVMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 13 years | - |
Gain YTD | 16.459 | 13.580 | 121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.64B | 23.8B | 11% |
Annual Yield % from dividends | 1.12 | 0.01 | 7,880% |
Returns for 1 year | 28.47 | 20.18 | 141% |
Returns for 3 years | 4.39 | 4.67 | 94% |
Returns for 5 years | 39.16 | 39.35 | 100% |
Returns for 10 years | -14.05 | 49.39 | -28% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TRICX | 4.90 | N/A | N/A |
Catalyst/SMH Total Return Income C | |||
FGDAX | 24.67 | -0.11 | -0.44% |
Fidelity Advisor Gold A | |||
JIVMX | 33.62 | -0.17 | -0.50% |
JPMorgan U.S. Applied Data Sci Val R6 | |||
ITRAX | 26.66 | -0.30 | -1.11% |
VY® T. Rowe Price Capital Apprec A | |||
BPSIX | 29.96 | -0.36 | -1.19% |
Boston Partners Small Cap Value II I |